Skip to main content

Table 3 Generalised linear model to predict MOH-3 membership

From: Insights into the clinical management of the syndrome of supine hypertension – orthostatic hypotension (SH-OH): The Irish Longitudinal Study on Ageing (TILDA)

Full sample

B

Std. error

P

Odds ratio

95% wald confidence interval for odds ratio

Lower

Upper

Female sex

0.55

0.08

<0.001

1.73

1.46

2.04

C07A (beta blockers)

0.47

0.12

<0.001

1.60

1.26

2.04

C08C (peripheral CCB)

−0.38

0.16

<0.001

0.68

0.49

0.94

N06A (antidepressants)

0.69

0.14

<0.001

1.99

1.50

2.64

Heart attack

−0.47

0.23

0.042

0.62

0.40

0.98

age

0.03

0.00

<0.001

1.03

1.03

1.04

Subsample ≥70 years old

B

Std. error

P

Odds ratio

95% wald confidence interval for odds ratio

Lower

Upper

Female sex

0.34

0.17

0.040

1.41

1.02

1.96

C07A (beta blockers)

0.44

0.19

0.021

1.55

1.07

2.25

C08C (peripheral CCB)

−0.60

0.27

0.025

0.55

0.33

0.93

N06A (antidepressants)

0.70

0.30

0.018

2.01

1.13

3.60

Diabetes

−0.62

0.33

0.064

0.54

0.28

1.04

Age

0.05

0.02

0.009

1.05

1.01

1.09

  1. Dependent variable: MOH type 3 (large drop, under-recovery). Binary logistic response, forward conditional procedure. Predictors entered: female sex, polypharmacy, C01A (cardiac glycosides), C01B (antiarrhythmics), C07A (beta blockers), C03 (diuretics), C09A (ACE-i), C09C (ARA), C08C (peripheral CCB), C08D (cardiac CCB), C02C (alpha blockers), C01D (cardiac vasodilators), C04A (peripheral vasodilators), N03A (antiepileptics), N05A (antipsychotics), N05B (anxiolytics), N05C (hypnotics, sedatives), N06A (antidepressants), hypertension, angina, heart attack, heart failure, diabetes, stroke¸ TIA, abnormal heart rhythm, Parkinson’s disease, three or more chronic diseases, any IADL disability, age.